Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold W Goforth

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|April 21, 2010
Hydromorphone-OROS formulationHarold W Goforth
Expert Opinion on Pharmacotherapy|June 6, 2009
Low-dose doxepin for the treatment of insomnia: emerging dataHarold W Goforth
Neurologic Clinics|January 31, 2012
Acute neurologic effects of alcohol and drugsHarold W Goforth, Francisco Fernandez
The Journal of ECT|April 17, 2007
Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapyHarold W Goforth, Tracey Holsinger
Journal of Opioid Management|February 25, 2016
Oxycodone with an opioid receptor antagonist: A reviewMellar P Davis, Harold W Goforth
AIDS and Behavior|April 13, 2011
A systematic review of the psychiatric side-effects of efavirenzChristopher A Kenedi, Harold W Goforth
Cancer Journal (Sudbury, Mass.)|October 10, 2014
Treatment of fatigue and sleep disorders in cancer patientsHarold W Goforth, Mellar P Davis
Cancer Journal (Sudbury, Mass.)|October 10, 2014
Long-term and short-term effects of insomnia in cancer and effective interventionsMellar P Davis, Harold W Goforth
Neurologic Clinics|November 26, 2009
Neurologic aspects of drug abuseHarold W Goforth, Reed Murtaugh, Francisco Fernandez
Expert Opinion on Drug Safety|March 29, 2013
Oxycodone combined with opioid receptor antagonists: efficacy and safetyMellar Davis, Harold W Goforth, Pam Gamier
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|April 21, 2010
Hydromorphone-OROS formulationHarold W Goforth
Expert Opinion on Pharmacotherapy|June 6, 2009
Low-dose doxepin for the treatment of insomnia: emerging dataHarold W Goforth
Neurologic Clinics|January 31, 2012
Acute neurologic effects of alcohol and drugsHarold W Goforth, Francisco Fernandez
The Journal of ECT|April 17, 2007
Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapyHarold W Goforth, Tracey Holsinger
Journal of Opioid Management|February 25, 2016
Oxycodone with an opioid receptor antagonist: A reviewMellar P Davis, Harold W Goforth
AIDS and Behavior|April 13, 2011
A systematic review of the psychiatric side-effects of efavirenzChristopher A Kenedi, Harold W Goforth
Cancer Journal (Sudbury, Mass.)|October 10, 2014
Treatment of fatigue and sleep disorders in cancer patientsHarold W Goforth, Mellar P Davis
Cancer Journal (Sudbury, Mass.)|October 10, 2014
Long-term and short-term effects of insomnia in cancer and effective interventionsMellar P Davis, Harold W Goforth
Neurologic Clinics|November 26, 2009
Neurologic aspects of drug abuseHarold W Goforth, Reed Murtaugh, Francisco Fernandez
Expert Opinion on Drug Safety|March 29, 2013
Oxycodone combined with opioid receptor antagonists: efficacy and safetyMellar Davis, Harold W Goforth, Pam Gamier
Pageof 3